May Newsletter

In this month’s issue, we’ve provided you with a few quick updates on our pharmacy’s new hours of operation, meds currently on national shortage, and the new FDA-approved nasal spray, Nayzilam (midazolam) for seizure clusters. Plus, you’ll be learning more about the following:

  • Our pharmacy’s team members: Jason Tran, Pharm.D (CEO/Owner) and Danielle Bashor (Executive Assistant/Business Operations Manager)

  • The surge in generic drug prices explained: lawsuit against our nation’s largest drug manufacturers

Download Our May News Letter Here

April Newsletter

In this month’s issue, we’ve provided you with a few quick updates on meds currently on national shortage and the new generic for Narcan nasal spray. Plus, you’ll be learning more about the following:

  • Our pharmacy’s team members Andy Vu, PharmD (Staff Pharmacist) and Vicky Serrano (Pharmacy Tech Supervisor)

  • **IMPORTANT: The DEA’s new regulations/tools for drug manufacturers and distributors, explaining why we had to adjust the quantity dispensed for Controlled Substances**

Download Our April Newsletter Here

March Newsletter

In this month’s issue, we’ve provided you with a few quick updates on our pharmacy’s new hours of operation and the meds currently on national shortage. Plus, you’ll be learning more about the following:

  • Our pharmacy’s team members Lang Ly, PharmD (Staff Pharmacist) and Kat Abitong (Pharmacy Technician)

  • **IMPORTANT: A description of common issues that better explain the sources of drug shortages**

  • An intro to CA Board of Pharmacy’s new bill requiring a unique serialized number on prescriptions for controlled substances

Download Our March Newsletter

February Newsletter

In this month’s issue, we’ve provided you with a few quick updates on our pharmacy’s new hours of operation, meds currently on national shortage, and the new generic for Advair Diskus. Plus, you’ll be learning more about the following:

  • Our pharmacy’s team members Wael Wassef, PharmD (Lead Pharmacist) and Rebecca Mace-Humble (Lead Technician)

  • **IMPORTANT: Whether or not hospice is excluded from prescribing naloxone with opioid prescription orders**

  • Why levofloxacin and ciprofloxacin should no longer be one of our top choices to treat infections

 

Download February Newsletter

January Newsletter

To kickstart the year, here is Care-Rx’s very own first newsletter. In this “inaugural” newsletter, you’ll be introduced to:

  • Our team members Alex Velasco, PharmD (Clinical Coordinator) and Andrew Minard (Pharmacy Tech Supervisor)

  • The endless possibilities made possible with compounding—a special type of personalized medicine that we’re happy to offer. **IMPORTANT: Please read to understand how compounding can play a critical role in patient care and to view some of our most popular and effective compounds for hospice.**

Click Here To Download Our January Newsletter